Internal Server Error

About New Venturetec

New Venturetec is a venture capital firm founded in 1997. It is primarily based out of Zug, Switzerland. As of Sep 2015, New Venturetec has invested in 5 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Series C round of voragotech.com Overall, New Venturetec portfolio has seen 1 IPO and 3 acquisitions including key companies like Myriad Genetics, Osiris and Iperia. Argo Global Capital co-invest with New Venturetec, sharing a substantial percentage of its portfolio. New Venturetec has team of 4 people including 3 partners.
Key Metrics
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A & Series C
Portfolio IPOs
Portfolio Acquisitions

New Venturetec's List of All Investments

New Venturetec has a portfolio of 5 companies. Their most notable investmentis in voragotech.comTheir portfolio spans across and United States. They have invested in Life Sciences, High Tech, Enterprise Applications and 2 other sectors, across stages such as Series A, Series C stages. Here is the list of all investments by New Venturetec:
Developer of molecular diagnostics and personalized medicine for cancer. The company discovers and commercializes molecular diagnostic tests that determine the risk of developing the disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties. The products include Endopredict for the detection of breast cancer and Prolasis for prostate cancer. It also provides diagnostic tests for hereditary cancers and Rheumatoid arthritis.

Key facts about Myriad Genetics

Provider of radiation-hardened microcontrollers and microprocessors. It designs and manufactures these components for aerospace, defense, and industrial applications requiring high reliability in extreme environments. The company utilizes a patented technology to harden commercially available semiconductor components, making them suitable for use in harsh conditions involving radiation and extreme temperatures. It also offers custom hardware and firmware solutions, tailored to specific mission needs. These solutions are designed to withstand single event effects and other challenges faced in demanding applications.

Key facts about voragotech.com

Osiris Therapeutics was founded based on stem cell technology discovered by researchers at Case Western Reserve University led by Dr. Arnold Caplan. Today the company is developing and marketing regenerative medicine products. Having developed the world’s first approved stem cell drug, the company continues to advance its research and development in biotechnology by focusing on innovation in regenerative medicine – including bioengineering, stem cell research and viable tissue based products. Osiris has achieved commercial success with products in orthopaedics, sports medicine and wound care, including BIO4™, Cartiform® and Grafix®.

Key facts about Osiris

  • Founded Year: 1992
  • Location: Baltimore (United States)
  • Annual Revenue: $143M as on Dec 31, 2018
  • Last Known Valuation: $*****
  • Stage: Acquired
  • Employee Count: 356 as on Dec 31, 2018
  • Investors: New Venturetec
  • Highlight: Acquired
Iperia (formerly known as Visual Telesystems) provides IperiaVX, a service delivery platform that provides VAS such as mobile, voice, video, conferencing and web messaging suites. The solution follows Service Oriented Architecture delivering the scale, reliability, and extensibility service providers expect in order to serve mission-critical enterprises and residential customers. It caters it solutions to enterprise, service providers, financial services, healthcare, retail, higher education, real estate, energy, pharmaceuticals, manufacturing, and more.

Key facts about Iperia

mPortal develops software to provide better user/customer experience across mobile, web and other devices. These services are used by telecom, cable and media providers. AT&T, Verizon, Reliance, Time Warner etc. were their customers. BroadSoft acquired mPortal to improve its UC solutions. 

Key facts about mPortal

  • Founded Year: 2000
  • Location: Mclean (United States)
  • Stage: Acquired
  • Total Funding till date: $4M
  • Employee Count: 84 as on Jan 31, 2026
  • Investors: New Venturetec
  • Latest Funding Round: Series A, Sep 26, 2005, $*****
  • Highlight: Acquired

New Venturetec's Investments by Stage

New Venturetec has made 2 investments in Series A stage with an average round size of $6.5M and 1 investment in Series C stage with an average round size of $10M.
Here are New Venturetec's investments by stage:
Stage of entry
No. of Investments
Series A
2
Series C
1
Breakdown of New Venturetec's investments by stage of entrySeries A (2)Series C (1)
Note: We have considered here, only first round of investments

New Venturetec's Investments by Sector

New Venturetec has a diverse portfolio, with companies operating in the Enterprise Applications, Semiconductors and Telecom. Notably, it has invested in 5 Enterprise (B2B) companies, 3 Tech companies, 2 Software companies and at least 1 company focusing on Consumer (B2C).
Here are New Venturetec's investments by sector:
Sector
No. of Investments
Enterprise Applications
1
Semiconductors
1
Telecom
1
Breakdown of New Venturetec's investments by sectorsEnterprise Applic... (1)Semiconductors (1)
Note: We have considered here, only first round of investments

New Venturetec's Investments by Geography

New Venturetec has made most investments in United States (3).

New Venturetec's recent investments

New Venturetec has not made any investment in 2026 so far.
Here are the most recent investments by New Venturetec:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Sep 01, 2015
United States
Series C
6607
-
Sep 26, 2005
United States
Series A
6119
-
Jun 10, 2003
United States
Series A
7618
-
Aug 06, 2001
United States
Series A
2836

IPOs and Publicly Listed companies in New Venturetec's Portfolio

1 of New Venturetec's portfolio company became public -  Myriad Genetics. It got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Oct 1995.
Here are New Venturetec's portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Oct 05, 1995
-
-
9312

Acquired companies in New Venturetec's Portfolio

3 companies from New Venturetec's portfolio have been acquired. The most recent acquisition were Osiris in Mar 2019 by Smith & Nephew for $660M.
Here are New Venturetec's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Mar 12, 2019
-
-
2169
Jun 04, 2015
Sep 26, 2005
Series A
1923
Apr 02, 2012
Aug 06, 2001
Series A
3074

Team profile of New Venturetec

New Venturetec has a team of 4 members including 3 Partners located in Switzerland. New Venturetec's team does not sit on the board of any company as of now.
Here is a list of all team members in New Venturetec:
Name
Designation
Location
Board Memberships
Contact Details
Partner
Zurich
-
-
Partner
Maienfeld
-
-
Partner
-
-
-

Co-investors of New Venturetec

Over the past 25 years, 2 investors have co-invested in New Venturetec's portfolio companies. This includes only funds.

  • Invested before New VenturetecVIMAC Ventures has invested before New Venturetec.
  • Top Co-investors of New VenturetecArgo Global Capital entered a company along with New Venturetec.

Recent News related to New Venturetec

View all news related to New Venturetec

FAQs about New Venturetec

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford